Perioperative Insulin Glargine Dosing Study

Completed · Phase 4

Conditions studied: Diabetes, Surgery

In brief

The main objective of this study is to compare three strategies of evening insulin glargine dosing to preoperative glucose values in patients with diabetes undergoing surgery to determine which dosing strategies most often achieves the admission target study values of 100-179 mg/dl.

Key facts

Study ID

NCT00309465

Run by

Tamra Dukatz

People needed

402

Starts

2005-10-01

Expected to finish

2009-10-01

Last updated by the study team

2012-12-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for Surgical Procedure
• Self Management of Diabetes
• Currently on Evening Insulin Glargine prescribed by Primary Care Physician
• Age 18 or over
• Able to Communicate Clearly over the Phone
• Pre-screened by Anesthesia Department > 48 hours prior to Surgery

You may not qualify if…

• On Glucocorticoid Medication
• On Insulin Glargine Dual Dosing or Sliding Scale Regimen
• History of Hypoglycemia Unawareness
• Pregnancy or Lactating Female
• On Insulin Glargine for < 3 months

Where it is running

• William Beaumont Hospital — Royal Oak, Michigan, United States
• William Beaumont Hospital — Troy, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.